MaxCyte

IPO

Best-in-Class Electroporation Systems

Public · Gaithersburg, United States · Founded 1999

Employees
51–200
Founded
1999
Business Model
B2B
Type
Public

About

MaxCyte's ExPERT platform is built on the company's proven, non-viral Flow Electroporation technology, designed to enable transfection with high efficiency at any scale, from discovery through GMP biomanufacturing. Built for flexibility and precision, the platform empowers researchers to engineer complex cells with confidence. MaxCyte's partnership-driven licensing model provides more than access to leading non-viral transfection technology, it offers a strategic pathway to clinic and commercialization through flexible licensing, expert support, and proven scalability, helping partners accelerate development while mitigating risk.

Summary

MaxCyte is a Biotech company based in Gaithersburg, United States, founded in 1999.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOAug 2021
$185.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MaxCyte on Indexed.vc
<a href="https://indexed.vc/companies/maxcyte"><img src="https://indexed.vc/api/badge/company/maxcyte" alt="MaxCyte on Indexed.vc" width="260" height="76" /></a>